NeoGenomics Reports Revenue of $25.1 Million and Record Adjusted EBITDA of $2.8 Million Driven by a 25% Increase in Test Volume in the Third Quarter of 2015
Go back to NeoGenomics Reports Revenue of $25.1 Million and Record Adjusted EBITDA of $2.8 Million Driven by a 25% Increase in Test Volume in the Third Quarter of 2015| NEOGENOMICS (NASDAQ: NEO) | Delayed: 17.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.38 | 52 Week High | $9.54 | |||
| Open | $17.38 | 52 Week Low | $5.49 | |||
| Day High | $17.38 | P/E | 434.50 | |||
| Day Low | $17.38 | EPS | $0.04 | |||
| Volume | 3,507 | |||||

